コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ty and erythema skin prick reaction to short ragweed.
2 DNA (AIC) in 25 adults who were allergic to ragweed.
3 anasal challenge (s.i.n.) with either OVA or ragweed.
4 change for boys except an increase in IgE to ragweed.
5 e for SPP in allergic sensitization to short ragweed.
6 [n=429], cypress [412], orchard grass [152], ragweed [127], birch [106], alnus japonica [110], mite (
8 e were immunized and challenged with a short ragweed Ag extract, known to induce a selective eosinoph
11 ximately 52 weeks of daily self-administered ragweed AIT of 1.5, 6, or 12 units of Ambrosia artemisii
13 Here, we present structures of methylated ragweed allergen Amb a 8, Amb a 8 in the presence of pol
14 studies with TLR-9 vaccines conjugated to a ragweed allergen demonstrate that they reduce symptoms o
15 mg/day for 3 days before and 13 days during ragweed allergen immunization) in BALB/c and C57BL/6 mic
16 ty and efficacy of a sublingual standardized ragweed allergen immunotherapy liquid extract for the tr
18 xposing participants with ragweed allergy to ragweed allergen in an environmental exposure chamber mo
19 have induced eosinophilic peritonitis using ragweed allergen in P-selectin-deficient, intracellular
20 ger a seasonal increase in IgE antibodies to ragweed allergen in the immunotherapy group after two ye
24 TRGTT motif prevented conalbumin-induced and ragweed allergen-induced allergic inflammation in mice.
25 ized, placebo-controlled crossover trial, 19 ragweed allergen-sensitive subjects who had previously p
33 ent of the hierarchy of T cell reactivity in ragweed allergens, which is distinct from that observed
34 ) (on Days 1, 2, 9, and 16) in three groups: ragweed allergic asthmatics with dual phase airway react
37 (group 1, 3, 4, 5, 8 and 11) in 20 American ragweed allergic patients determined by FluoroSpot and p
39 used a segmental Ag challenge (SAC) model in ragweed-allergic asthmatics and nonasthmatic patients an
40 he GCR binding affinity (Kd) was observed in ragweed-allergic asthmatics during ragweed pollen season
41 characterized T cell responses from atopic, ragweed-allergic subjects to Amb a 1, Amb a 3, Amb a 4,
42 dred twenty-eight patients with a history of ragweed allergy and positive skin prick test responses t
44 estion induced by exposing participants with ragweed allergy to ragweed allergen in an environmental
45 s revealed that 50 (54%) of 92 patients with ragweed allergy were sensitized to a 37-kDa allergen dis
53 ophagoides farinae, dog, cat, timothy grass, ragweed, Alternaria alternata, egg, peanut, milk, and Ge
54 pitopes and homologous peptides from western ragweed (Amb p), giant ragweed (Amb t) and mugwort (Art
55 peptides from western ragweed (Amb p), giant ragweed (Amb t) and mugwort (Art v) were investigated in
56 ic-related pollution on the allergenicity of ragweed (Ambrosia artemisiifolia L.) pollen through a fi
57 range of a globally invasive species, common ragweed (Ambrosia artemisiifolia L.), from a temperature
64 to simulate the invasion of Europe by common ragweed (Ambrosia artemisiifolia), a globally invasive p
65 s (dust mite (Dematophagoides farinae), cat, ragweed (Ambrosia artemisiifolia), and timothy grass (Ph
68 h OVA but also with two unrelated allergens (ragweed and BSA) induced Vgamma4(+) cells capable of sup
71 IgE to mite and cat and decreases in IgE to ragweed and timothy from 2 to 4 years of age, whereas th
73 on-interventional studies of SQ grass, tree, ragweed, and house dust mite (HDM) SLIT tablets were ide
74 ity to the aeroallergens Der P 1 and 2, cat, ragweed, and mouse was compared in cases and controls.
75 lences of sensitization to Der p 1, Der p 2, ragweed, and mouse were low and similar in the two group
77 hay-fever symptoms, skin-test sensitivity to ragweed, and sensitivity to bronchial challenges and inc
79 fluid (BALF) before and 24 h after segmental ragweed antigen challenge in 18 asthmatic subjects at ba
82 Aeroallergens such as Amb a I from short ragweed are important in the development of allergic air
84 nsins such as Art v 1 (mugwort) and Amb a 4 (ragweed) are pivotal allergens in pollen-food syndromes,
85 l challenges and increased IgG antibodies to ragweed as compared with the placebo group; there was no
86 a disease, "pollen" as a disease cause and "ragweed" as a plant was needed to fully assess the polle
87 For regionally occurring pollen allergens (ragweed, birch, cypress), IgE sensitization was signific
94 l cross-sectional area (A(min)) after bolus (ragweed) complete nasal allergen challenge at screening
95 er, ash, birch, hazel, grasses, mugwort, and ragweed) considering personal sensitization and exposure
97 ll responses correlated with conservation of ragweed epitopes with sequences of other well-known alle
98 r adults with asthma exacerbated by seasonal ragweed exposure had positive effects on objective measu
100 r airway challenge with nebulized Amb a I or ragweed extract in mice sensitized to Amb a I or ragweed
103 were randomly assigned to receive placebo or ragweed-extract immunotherapy in doses that increased we
104 (PBMCs) from donors positive for IgE towards ragweed extracts after in vitro expansion for secretion
112 n cells (4 x 106 cells/ml) isolated from the ragweed-immunized mice (controls) were cultured in the p
115 icited after out-of-season exposure to short ragweed in a PCC and during the natural season for giant
116 ynergy was also observed between the DEP and ragweed in altering the profile of epsilon mRNAs generat
117 h ragweed alone, challenge with both DEP and ragweed induced markedly higher ragweed-specific IgE but
119 betaTCR(+)) CD4(+)CD25(+) T cells suppressed ragweed-induced airway hyperresponsiveness and inflammat
122 et (AIT; SCH 39641/MK-3641) for treatment of ragweed-induced AR/C in the first large randomized, doub
129 se, adults with asthma who were sensitive to ragweed kept daily diaries and recorded peak expiratory
130 ctive was to assess the clinical efficacy of Ragweed MATA MPL (short ragweed pollen allergoid adsorbe
131 evaluate the clinical efficacy and safety of Ragweed MATA MPL compared with placebo by using controll
132 n improvement in total symptom scores in the Ragweed MATA MPL group was statistically significantly g
133 dy demonstrated that an ultrashort course of Ragweed MATA MPL is efficacious in reducing allergy symp
135 n patients with unexplained sensitization to ragweed, mugwort, pellitory, Plantago and plane tree pol
136 ents with sensitization to various extracts (ragweed, mugwort, pellitory, Plantago, and plane tree),
137 o mountain cedar (n = 21), oak (n = 34), and ragweed (n = 23) recorded TSSs during separate out-of-se
140 tic characteristics, efficacy, and safety in ragweed- or birch pollen-induced seasonal allergic rhini
141 significantly reduced after incubation with ragweed (p < 0.001) or cat allergen (p < 0.001) compared
142 Mature pollen grains were collected from ragweed plants grown along main roadsides and in vegetat
143 receptor blocks and a total of 100,938 giant ragweed plants were screened with glyphosate applied at
145 derstand the effects of chemically processed ragweed pollen (Ambrosia elatior) on the innate immune s
146 This study has shown that in response to ragweed pollen all these cells release inflammatory cyto
147 all minor (Amb a 3, 4, 5, 6, 8 and 9) short ragweed pollen allergen repertoire as well as NADH oxida
148 cross-reactivity might be Amb a 1, the major ragweed pollen allergen, and Art v 6, a highly homologou
149 gest that traffic-related pollution enhances ragweed pollen allergenicity, which may contribute to th
150 clinical efficacy of Ragweed MATA MPL (short ragweed pollen allergoid adsorbed to L-Tyrosine + MPL) v
151 Our quantitative estimates indicate that ragweed pollen allergy will become a common health probl
153 measured mass spectra from materials such as ragweed pollen and road dust that are likely to form a b
156 elated with spatial and temporal patterns of ragweed pollen concentrations, which are fully independe
157 Hosts sensitized cutaneously with short ragweed pollen developed cutaneous immediate hypersensit
159 After cellular oxidative insult induced by ragweed pollen extract (RWE) exposure, we have identifie
162 challenge with Amb a 1, the major antigen in ragweed pollen extract that does not possess NADPH oxida
165 days under Th2-like conditions with aqueous ragweed pollen extracts (Amb-APE) or its constituents.
167 these participants were challenged to short ragweed pollen in a PCC for 3 hours per day for up to 4
168 entify critical factors for allergenicity of ragweed pollen in a physiological model of allergic airw
169 ergic rhinoconjunctivitis symptoms caused by ragweed pollen in an environmental exposure chamber (EEC
172 eated with daily birch pollen, grass pollen, ragweed pollen or house dust mite AIT in tablet form wer
173 climate change, have been shown to increase ragweed pollen production, but their effects on pollen a
175 en source planted in the center and GS giant ragweed pollen receptors surrounding the center in eight
178 a significant increase in the length of the ragweed pollen season by as much as 13-27 d at latitudes
179 served in ragweed-allergic asthmatics during ragweed pollen season compared with PBMC obtained before
181 that besides transporting the vaccine cargo, ragweed pollen shells have additional immunomodulatory p
182 ted in a concentric design with the GR giant ragweed pollen source planted in the center and GS giant
183 e sensitized by topical application of short ragweed pollen to the nasal mucosa followed by a challen
185 imental Ag, OVA, or a common allergen, short ragweed pollen, induced no or minimal immune responses t
186 include respiratory allergens from birch and ragweed pollen, midge larvae, and horse dander; food all
193 trial of a vaccine consisting of Amb a 1, a ragweed-pollen antigen, conjugated to a phosphorothioate
194 en-derived adenosine is a critical factor in ragweed-pollen-induced allergic airway inflammation.
197 the most prevalent allergies (e.g. grass and ragweed pollens, dust mites, and cat) and those that ind
198 symptom score [TSS]) during the VLO, MC, and ragweed pollinating seasons and during 2 consecutive PCC
199 n cedar (MC)-positive, 8 MC-negative, and 26 ragweed-positive participants recorded AR symptoms (tota
201 will increase in countries with an existing ragweed problem (e.g., Hungary, the Balkans), but the gr
204 Ascaris suum (A. suum) eggs concurrent with ragweed (RW) sensitization (RW/acute) or by repeated ino
205 tions starting in 1950 accurately reproduced ragweed's current distribution, including the presence o
208 acebo (n = 136) subcutaneously just prior to ragweed season and repeated during the pollen season eve
209 the AIC or placebo vaccine before the first ragweed season and were monitored during the next two ra
213 of AIC were again observed in the subsequent ragweed season, with improvements over placebo in peak-s
220 antly increased in the blood of serum IgE(+) ragweed-sensitized (RS) compared with serum IgE-nonatopi
223 hy grass SLIT-tablet trials (n = 3094) and 2 ragweed SLIT-tablet trials (n = 658) and during the last
225 cts on nasal symptoms with timothy grass and ragweed SLIT-tablets were nearly as great as with MFNS a
229 highly cross-reactive to epitopes of related ragweed species without any apparent geographical respon
232 both DEP and ragweed induced markedly higher ragweed-specific IgE but not total IgE levels or IgE-sec
233 early and late dosages, strikingly decreased ragweed-specific serum IgE, tracheal ring reactivity to
234 terize the proteomes and allergomes of short ragweed SPP and total pollen protein extract (TOT), and
237 ular basis of immune responsiveness to short ragweed (SRW) (Ambrosia artemisiifolia) extract, and gro
238 ce were sensitized in the footpad with short ragweed (SRW) allergen and challenged topically for seve
240 naive A/J mice, A/J mice sensitized to short ragweed (SRW) pollen by intraperitoneal injection and th
241 tal allergic conjunctivitis induced by short ragweed (SRW) pollen, typical allergic signs, stimulated
242 phils and eosinophils toward supernatants of ragweed-stimulated bronchial epithelial cells was analyz
243 isolated from the chitin-treated mice showed ragweed-stimulated IFN-gamma production (15 U/ml) and si
245 /c allergic hosts was analyzed using a short ragweed (SWR) pollen model of allergic conjunctivitis.
247 llergen extracts (English plantain, mugwort, ragweed, timothy grass, ash tree, mites, dog, cat, Alter
249 nt (GR) to glyphosate-susceptible (GS) giant ragweed under simulated field conditions using glyphosat
250 gens from short and giant (Ambrosia trifida) ragweed using transgenic mice expressing DQ6 (HLA-DQA1*0
252 /J mice sensitized and challenged with short ragweed was used to test immunostimulatory DNA sequences
254 gy and positive skin prick test responses to ragweed were randomized and received 4 weekly injections
257 ry estimates indicated that sensitization to ragweed will more than double in Europe, from 33 to 77 m